Background

In the summer of 2003, Urodynamix’s NIRS technology was discovered by researchers at the University of British Columbia (UBC) in Vancouver, British Columbia. The UBC researchers made a unexpected observation while using near infrared spectroscopy (NIRS) to monitor tissue oxygenation and blood flow in the lower lumbar spinal cord area (unrelated to urology). When the research subject spontaneously voided during the procedure, a significant change was noticed in the continuous NIRS tracings. The researchers concluded that these changes were indicative of changes in bladder physiology. This discovery led to the development of Urodynamix’s URO-NIRS Bladder Monitor technology. 

Subsequent Milestones

• In May 2005, Urodynamix completed a License Agreement with the University of British Columbia for the exclusive global rights to develop, manufacture and market the technology.

• In May 2007, Urodynamix entered into a worldwide distribution agreement granting Laborie Medical Technologies, the world leader in urodynamics systems and pelvic-floor diagnostic devices, worldwide distribution rights to the URO-NIRS Bladder Monitor.

• At the end of 2007, a pivotal clinical study was completed. Marketing trials at high-profile clinical sites in North America and Europe will be initiated by Laborie to support the launch of the Tetra™ Bladder Monitor System in 2008.